On April 4, Terence Rice, Vice President & Chief Information Security Officer (CISO) at Merck & Co., Inc. presented a concern to the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce-he stated that cybersecurity in the healthcare industry is much worse than is narrated. He suggested that solutions will require a transparent partnership of both public and private.
Rice cited the 2016 IBM Cyber Security Intelligence Index, which reports the healthcare industry as the most attacked industry, with reasons on why risks to the industry are understated in media reports. He believes that organizational concerns about reputational damage, the inadequate resources of smaller businesses, the transferability of healthcare information, and the abundance of software for healthcare are all factors in cybersecurity risks.
He is confident, however, that with initiatives that are already put in place-the Department of Health & Human Services Sector Coordinating Council; NH-ISAC, an alliance of more than 200 companies in the industry; and SAFE-BioPharma Association-plus additional opportunities for collaboration, the enhancement of a greater healthcare cybersecurity is possible.
To read Rice’s full testimony and learn more about his recommended additional opportunities, click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.